Celularity Non Currrent Assets Other from 2010 to 2024
| CELU Stock | USD 2.76 0.09 3.16% |
Non Currrent Assets Other | First Reported 2019-03-31 | Previous Quarter 26.9 M | Current Value 24.8 M | Quarterly Volatility 97 M |
Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Interest Expense of 2.8 M, Ebit of 17.2 M or Net Income Applicable To Common Shares of 17.1 M, as well as many indicators such as Price To Sales Ratio of 1.84, Dividend Yield of 0.0 or PTB Ratio of 1.13. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
Celularity | Non Currrent Assets Other |
Latest Celularity's Non Currrent Assets Other Growth Pattern
Below is the plot of the Non Currrent Assets Other of Celularity over the last few years. It is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. Celularity's Non Currrent Assets Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Celularity's overall financial position and show how it may be relating to other accounts over time.
| Non Currrent Assets Other | 10 Years Trend |
|
Non Currrent Assets Other |
| Timeline |
Celularity Non Currrent Assets Other Regression Statistics
| Arithmetic Mean | (21,679,583) | |
| Coefficient Of Variation | (569.16) | |
| Mean Deviation | 59,099,256 | |
| Median | 149,750 | |
| Standard Deviation | 123,392,007 | |
| Sample Variance | 15225.6T | |
| Range | 504.7M | |
| R-Value | (0.03) | |
| Mean Square Error | 16381.2T | |
| R-Squared | 0.001 | |
| Significance | 0.91 | |
| Slope | (851,585) | |
| Total Sum of Squares | 213158.2T |
Celularity Non Currrent Assets Other History
About Celularity Financial Statements
Celularity shareholders use historical fundamental indicators, such as Non Currrent Assets Other, to determine how well the company is positioned to perform in the future. Although Celularity investors may analyze each financial statement separately, they are all interrelated. The changes in Celularity's assets and liabilities, for example, are also reflected in the revenues and expenses on on Celularity's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Non Currrent Assets Other | 26.9 M | 28.3 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.